Business model

Our strength

• A unique formulation ensuring preservation of enzymes activity in the human GIT. 
• This formula is covered by patents issued in USA, Canada and EU.
• The concept of the bi-enzymatic formula was proven in animal models showing its efficiency.
• Extensive knowledge of histamine/ DAO topic and partners in scientific and business area.

Private company committed to contribute to the new way to treat people using natural molecules and mechanisms. 

Histapharm main objective is to develop products intended to prevent, to alleviate or to treat multifactorial symptoms and diseases related to histamine dysfunctions.

Open to collaborate with partners in financial, distribution and healthcare domains, contact guy.bilodeau@histapharm.com